CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
For the period ended Jun 30, 2025. Filed Aug 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 8, 2025
CELZ$0.62+2.6%Stored close · as of Nov 6, 2026
Contents
Unaudited Condensed Consolidated Balance Sheets
| UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS | ||
|---|---|---|
| June 30, 2025 | December 31, 2024 | |
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash | $6,544,120 | $5,940,402 |
| Inventory | 994 | 2,194 |
| Prepaids and other current assets | 87,593 | 192,707 |
| Total Current Assets | 6,632,707 | 6,135,303 |
| OTHER ASSETS | ||
| Other assets | 3,281 | 3,281 |
| Licenses, net of amortization | 469,240 | 530,559 |
| TOTAL ASSETS | $7,105,228 | $6,669,143 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| CURRENT LIABILITIES | ||
| Accounts payable | $263,450 | $273,530 |
| Accrued expenses | - | 39,920 |
| Advances from related party | 14,194 | 14,194 |
| Total Current Liabilities | 277,644 | 327,644 |
| TOTAL LIABILITIES | 277,644 | 327,644 |
| STOCKHOLDERS' EQUITY | ||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized, 0 outstanding at June 30, 2025 and December 31, 2024 | - | - |
| Common stock, $0.001 par value, 25,000,000 shares authorized; 2,585,532 and 1,748,428 issued and 2,580,532 and 1,748,428 outstanding at June 30, 2025 and December 31, 2024, respectively | 2,586 | 1,749 |
| Additional paid-in capital | 74,298,311 | 70,931,663 |
| Accumulated deficit | (67,463,313) | (64,591,913) |
| Treasury stock, at cost, 5,000 and 0 shares as of June 30, 2025 and December 31, 2024, respectively | (10,000) | - |
| TOTAL STOCKHOLDERS' EQUITY | 6,827,584 | 6,341,499 |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $7,105,228 | $6,669,143 |
The accompanying notes are an integral part of these condensed consolidated financial statements
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | |||||
|---|---|---|---|---|---|
| UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||
| For the Three Months Ended June 30, 2025 · For the Three Months Ended June 30, 2024 · For the Six Months Ended June 30, 2025 · For the Six Months Ended June 30, 2024 | |||||
| Revenues | $ | - | $8,000 | $3,000 | $8,000 |
| Cost of revenues | - | 3,200 | 1,200 | 3,200 | |
| Gross profit | - | 4,800 | 1,800 | 4,800 | |
| OPERATING EXPENSES | |||||
| Research and development | 501,261 | 924,749 | 1,244,565 | 1,347,141 | |
| Selling, general and administrative | 731,517 | 676,086 | 1,619,914 | 1,347,570 | |
| Amortization of patent costs | 30,742 | 29,271 | 61,319 | 58,542 | |
| TOTAL EXPENSES | 1,263,520 | 1,630,106 | 2,925,798 | 2,753,253 | |
| Operating loss | (1,263,520) | (1,625,306) | (2,923,998) | (2,748,453) | |
| OTHER INCOME/(EXPENSE) | |||||
| Interest income | 30,217 | 67,578 | 52,598 | 149,181 | |
| Total other income (expense) | 30,217 | 67,578 | 52,598 | 149,181 | |
| LOSS BEFORE PROVISION FOR INCOME TAXES | (1,233,303) | (1,557,728) | (2,871,400) | (2,599,272) | |
| Provision for income taxes | - | - | - | - | |
| NET LOSS | $(1,233,303) | $(1,557,728) | $(2,871,400) | $(2,599,272) | |
| NET LOSS PER SHARE - BASIC AND DILUTED | $(0.48) | $(1.11) | $(1.26) | $(1.84) | |
| WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED | 2,580,532 | 1,405,208 | 2,282,290 | 1,413,324 | |
The accompanying notes are an integral part of these condensed consolidated financial statements
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.